Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
200-559-2
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Revision date
2014-02-03
Product name
Lincomycin Hydrochloride Soluble Powder
Product name
Lincomycin Hydrochloride Soluble Powder
Identification on the label/Trade name
Lincomix
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Appearance: White to off-white powder
2.1 Classification of the substance or mixture
Skin Sensitization: Category 1 US OSHA Specific - Classification
Physical hazards
Combustible Dust
EU Classification
EU Indication of danger: Irritant EU Symbol: Xi EU Risk Phrases: R43 - May cause sensitization by skin contact.
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction May form combustible dust concentrations in air
Precautionary statements
P210 - Keep away from heat/sparks/open flames/hot surfaces. - No smoking P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P272 - Contaminated work clothing should not be allowed out of the workplace P280 - Wear protective gloves/protective clothing/eye protection/face protection P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P362 - Take off contaminated clothing and wash before reuse P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
Short Term: May cause eye, skin and respiratory tract irritation. Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Known Clinical Effects: The most common adverse effects reported with clinical use were diarrhea, nausea, rash, and vomiting. Effects on blood and blood-forming organs have also occurred. This compound can cross the placenta in pregnant women. Secreted in human breast milk. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
